This is informed speculation, not proven protocol
JAMA Internal Medicine 2020, 180: 542-551
J Physiol Biochem (2016) 72:37180
One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management
GLP-1 Offerings and Weight Loss Services ShedRx offers the most diverse medication format menu in this review series: Compounded Semaglutide (4 formats): Weekly injectable: compounded semaglutide injections from $199/month GLP-1 Liquid Drops: daily sublingual drops absorbed under the tongue from $229/month GLP-1 Lozenges: daily dissolvable lozenges from $199/month Liposomal tablets: additional oral format Compounded Tirzepatide (2 formats): Weekly injectable: from $199/month Sublingual drops format also available Brand-Name Options (with $99/month membership): Wegovy and Zepbound FDA-approved injectable GLP-1s, available for patients who prefer pharmaceutical-grade brand-name products
